Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
7/9/2024 | $28.00 → $30.00 | Neutral → Buy | UBS |
6/7/2024 | $25.00 | Neutral | Mizuho |
4/9/2024 | $19.00 → $34.00 | Underperform → Outperform | BMO Capital Markets |
3/5/2024 | $37.00 → $21.00 | Buy → Neutral | UBS |
2/29/2024 | $45.00 → $19.00 | Outperform → Underperform | BMO Capital Markets |
12/1/2023 | $28.00 → $40.00 | Sector Perform → Outperform | RBC Capital Mkts |
6/22/2023 | $41.00 → $37.00 | Buy → Neutral | BofA Securities |
1/24/2023 | $31.00 → $43.00 | Neutral → Buy | UBS |
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
3 - Chemours Co (0001627223) (Issuer)
The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the fourth quarter of 2024. The dividend will be paid on December 16, 2024 to stockholders of record as of the close of business on November 15, 2024. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solu
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its third quarter 2024 financial results before market on Monday, November 4, 2024. The Company expects to hold its conference call to discuss its third quarter 2024 financial results at 8:00 a.m. Eastern Standard Time on Monday, November 4, 2024. The call is open to the public and can be accessed via the below webcast information. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE:CC)
The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the third quarter of 2024. The dividend will be paid on September 13, 2024 to stockholders of record as of the close of business on August 15, 2024. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a
UBS upgraded Chemours from Neutral to Buy and set a new price target of $30.00 from $28.00 previously
Mizuho initiated coverage of Chemours with a rating of Neutral and set a new price target of $25.00
BMO Capital Markets upgraded Chemours from Underperform to Outperform and set a new price target of $34.00 from $19.00 previously
8-K - Chemours Co (0001627223) (Filer)
10-Q - Chemours Co (0001627223) (Filer)
8-K - Chemours Co (0001627223) (Filer)
The Chemours Company (Chemours) (NYSE:CC) today announced the pricing of its previously announced private offering of $600,000,000 aggregate principal amount of new 8.000% senior notes due 2033 (the "Notes"). The Notes will bear interest at 8.000% per annum and mature on January 15, 2033. Interest on the Notes will be payable semi-annually on January 15 and July 15 of each year, beginning on July 15, 2025. The Notes will be senior unsecured obligations of Chemours and will be guaranteed by certain of its subsidiaries. The offering is expected to close on November 27, 2024, subject to customary closing conditions. Chemours intends to use the net proceeds from the offering to redeem all of
The Chemours Company (Chemours) (NYSE:CC) today announced that it intends to offer $600,000,000 aggregate principal amount of new senior notes due 2033 (the "Notes"), subject to market and other conditions. The Notes will be senior unsecured obligations of Chemours and will be guaranteed by certain of its subsidiaries. Chemours intends to use the net proceeds from the offering to redeem all of its outstanding euro-denominated 4.000% senior notes due 2026 and the remainder of the net proceeds for general corporate purposes. The Notes and related guarantees are being offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securitie
The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the fourth quarter of 2024. The dividend will be paid on December 16, 2024 to stockholders of record as of the close of business on November 15, 2024. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solu
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
UBS analyst Joshua Spector upgrades Chemours (NYSE:CC) from Neutral to Buy and raises the price target from $28 to $30.
Mr. Satterthwaite Brings Over 30 Years of Global Power Generation Experience to Amprius Technologies Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE:AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, has appointed Livingston "Tony" Satterthwaite as an independent director on its Board of Directors (the "Board"), effective August 13, 2024. Mr. Satterthwaite will also be joining the Board's Compensation Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240814317462/en/Amprius Appoints Transportation Industry Veteran Tony Satterthwaite to Board of Directors (Photo: Busi
The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Livingston "Tony" Satterthwaite to its Board of Directors, effective June 12. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240613653963/en/Tony Satterthwaite named to Chemours' Board of Directors (Photo: Business Wire) "I'm pleased to welcome Tony as the newest member of Chemours' Board of Directors," said Dawn Farrell, Chair of the Board of Chemours. "Tony brings extensive leadership and board expe
The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Shane Hostetter as Chief Financial Officer (CFO) effective July 1, 2024. As CFO, Shane will lead Finance, Investor Relations, Corporate Development, Strategy, and Enterprise Risk Management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240605314740/en/Shane Hostetter, Chief Financial Officer (Photo: Business Wire) "Shane is a welcome addition to the Chemours team. With over 20 years' experience in a